Neuroprotection protocols using peptides for neuronal survival, neuroinflammation reduction, and neurodegenerative risk mitigation. The peptide revolution promises to rewire your brain, but your immune system might have other plans. From Dihexa's synaptogenic hammer to Cerebrolysin's clinical track record, this hub maps the compounds targeting neuronal survival. Pinealon bypasses the blood-brain barrier and directly modulates gene expression. Selank and Semax — two sister peptides from the same Cold War lab — anchor the pharmacology for anxiety, BDNF upregulation, and Default Mode Network modulation.
From Dihexa's synaptogenic hammer to Cerebrolysin's clinical track record — five realities of the peptide cognition frontier, and the regulatory minefield around them.
A three-amino-acid peptide that bypasses the blood-brain barrier, enters the nucleus, and directly modulates gene expression for neuroprotection.
A tuftsin-derived heptapeptide that delivers benzodiazepine-level anxiety relief without sedation, dependence, or cognitive fog — while simultaneously boosting immune defence.
An ACTH-derived heptapeptide that upregulates BDNF, modulates the Default Mode Network, and delivers 20-24 hours of neuroprotection per dose — without a single hormonal side effect.
A four-amino-acid peptide that activates telomerase, remodels chromatin, and restores melatonin synthesis from the pineal gland — addressing five hallmarks of aging simultaneously. The Russian clinical data spans 12–15 years. Independent Western replication barely exists.
Cerebrolysin is a porcine-brain peptide mixture sold as a master key for brain repair. It has decades of human trials, approval in 50+ countries, no FDA approval, and a Cochrane safety signal that complicates the story.
DSIP was named for inducing delta sleep, but independent labs failed to replicate that in humans, no one has found its receptor or gene, and its best human stress trial found zero effect. Fascinating biology, unproven clinically.
The biochemical cofactors your body needs to support Pinealon therapy.
The biochemical cofactors your body needs to support Selank therapy.
The biochemical cofactors your body needs to support Semax therapy.
Two sister peptides from the same Cold War lab, one calms the emotional floor, the other raises the cognitive ceiling. The mechanistic case for stacking them is architecturally compelling. The clinical evidence for the combination doesn't exist yet.
HPTA recovery after testosterone therapy takes far longer than forums claim. Established PCT has limits, and peptides offer a mechanistically compelling but clinically unproven layer on top.